US2300311063
US2300311063
Cullinan Therapeutics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 999.43M EUR | 1.17B EUR | 873.22M EUR |
Enterprise Value | 662.46M EUR | 1.1B EUR | 800.53M EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -5.65x | -- | -- |
Price to Sales | -- | -- | -- |
Price to Book | 3.11x | 3.64x | 2.38x |
EV/Revenue | -- | -- | -- |
EV/EBITDA | -2.99x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -8.93% | -13.6% | -20.46% |